Cost-Minimization Analysis of Metformin and Acarbose in Treatment of Type 2 Diabetes
نویسندگان
چکیده
Background: Metformin is the first-line oral hypoglycemic agent for type 2 diabetes mellitus (T2DM) per international guidelines with proven efficacy, safety, and cost-effectiveness. However, little information comparing it with acarbose exists. Objective: To study the costeffectiveness of metformin and acarbose—two extensively adopted agents—in treating T2DM. Methods: Cost-minimization analysis was conducted on the assumption that metformin and acarbose have equivalent clinical effectiveness. The cost of treatment was detected and evaluated from a payer’s perspective. In sensitivity analyses, several clinical scenarios were developed according to clinical practices and physicians’ prescribing behaviors in China. Results: Metformin can save annual treatment costs by 39.87% to 40.97% compared with acarbose. ee front matter Copyright & 2015, International S
منابع مشابه
Evaluation of Serum Vaspin and Chemerin Levels in Type 2 Diabetic and Treated with Anti Diabetic Drugs Metformin and Acarbose in Rats
Background & Objective: The serum levels of adipose tissue hormons, Vaspin and Chemerin, alter in some disorder conditions such as diabetes. The aim of this study is to investigate the effect of two anti-diabetic drugs (Metformin and Acarbose) and their combination on serum concentration of Vaspin and Chemerin in type 2 diabetic rats. Materials & Methods: 30 male, wistar rats are randomly d...
متن کاملاثرهای درمانی متفورمین و آکاربوز و ترکیب این دو دارو بر سطح ویسفاتین سرم در موشهای صحرایی مبتلا به دیابت نوع2 القاشده توسط نیکوتینآمید و استرپتوزوسین
Background and Objective: Metformin and acarbose are two drugs, currently used for treatment of diabetes. The present study examined their effect, alone or combined together, on glycemic control, lipid profile and serum visfatin level in nicotinamide/streptozocin type 2 diabetic rats. Materials and Methods: Type 2 diabetes was induced in male Wistar rats by a single intraperitoneal injection...
متن کاملCost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City
INTRODUCTION Worldwide, diabetes mellitus presents a high burden for individuals and society. In Latin America, many people with diabetes have limited access to health care, which means that indirect costs may exceed direct health care cost. Diabetes is Mexico's leading cause of death. PURPOSE To evaluate the cost-effectiveness ratios of the most used oral hypoglycemic agents (OHA) in the tre...
متن کاملAcarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.
BACKGROUND Metformin is the only first-line oral hypoglycaemic drug for type 2 diabetes recommended by international guidelines with proven efficacy, safety, and cost-effectiveness. However, little information exists about its use in Asian populations. We aimed to ascertain the effectiveness of the α-glucosidase inhibitor acarbose, extensively adopted in China, compared with metformin as the al...
متن کاملComparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
This study, a subgroup analysis of the data from the Organization Program of DiabEtes INsulIN ManaGement study, aimed to compare the efficacy and safety profiles of acarbose and metformin used in combination with premixed insulin.This analysis included 80 and 192 patients taking only 1 oral antidiabetic drug, classified into acarbose (treated with acarbose + insulin) and metformin groups (treat...
متن کامل